Data analysis has a rich history that spans centuries, evolving alongside human civilization’s increasing need to understand patterns, make predictions, and optimize decisions. In ancient times, ...
Per Sage Therapeutics, the BIIB offer significantly undervalues the company and is not in the best interest of shareholders. Biogen currently owns a 10.2% stake in SAGE, per a SEC filing by the ...